IM vs. Subcutaneous: Which Testosterone Injection is Right for You?
Share
When it comes to Testosterone Replacement Therapy (TRT), one of the most common and effective methods of administration is via injection. But not all injections are the same. Testosterone Cypionate can be administered in two primary ways: intramuscularly (IM), deep into the muscle, or subcutaneously (SC), into the fatty tissue just under the skin.
While both methods are effective, a growing body of research shows that subcutaneous injections may offer a better overall profile for safety and patient comfort. Let's look at what the studies say.
Effectiveness and Hormone Levels
The primary goal of TRT is to raise testosterone to healthy, therapeutic levels. On this front, both methods deliver. Studies confirm that both IM and SC injections reliably increase total testosterone to therapeutic levels in men, with no significant difference in the overall testosterone levels achieved. Both methods also provide stable testosterone levels between doses.
Where we do see a difference is in two other important markers: Estradiol (E2) and hematocrit (HCT). Research has shown that both E2 and HCT levels tend to be lower after subcutaneous injections compared to intramuscular ones. This suggests SC injections may have a safer profile regarding estrogen-related side effects and changes in blood viscosity.
Patient Comfort and Preference
For a therapy that requires regular self-administration, comfort and ease of use are paramount. Here, subcutaneous injections have a clear advantage. Studies consistently show that SC injections, which use a much smaller needle, are:
Less painful.
Easier to self-administer.
Generally preferred by most patients who have tried both methods.
Minor, temporary skin irritation can occur with SC injections, but it is typically mild and rare.
Overall Safety Profile
Both methods are considered safe and effective when done under medical supervision. However, the data suggests that subcutaneous injections are associated with fewer side effects related to elevated estradiol and hematocrit. Importantly, no significant differences in prostate-specific antigen (PSA) changes or other serious adverse events have been found between the two methods.
Conclusion
Choosing an injection method is a key part of personalizing your TRT plan. While both IM and SC injections are effective, subcutaneous injections offer the same hormonal benefits with potentially fewer side effects and greater patient comfort and convenience, making them a strong alternative to traditional intramuscular injections.
To learn more about what a personalized, medically supervised TRT plan could look like for you, book a free, no-obligation consultation with our clinical team.
Baines, H., & Connelly, K. (2023). A prospective comparison study of subcutaneous and intramuscular testosterone injections in transgender male adolescents. Journal of Pediatric Endocrinology and Metabolism, 36, 1028 - 1036.
Choi, E., Xu, P., Barham, D., El-Khatib, F., Yafi, F., & Kavoussi, P. (2021). Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. The Journal of Urology, 207, 677 - 683.
Choi, E., Xu, P., Loeb, C., El-Khatib, F., Yafi, F., & Kavoussi, P. (2022). Intramuscular testosterone cypionate vs subcutaneous testosterone enanthate: Comparing the outcomes in hypogonadal men. The Journal of Sexual Medicine.
McFarland, J., Craig, W., Clarke, N., & Spratt, D. (2017). Serum Testosterone Concentrations Remain Stable Between Injections in Patients Receiving Subcutaneous Testosterone. Journal of the Endocrine Society, 1, 1095 - 1103.
Spratt, D., Stewart, I., Savage, C., Craig, W., Spack, N., Chandler, D., Spratt, L., Eimicke, T., & Olshan, J. (2017). Subcutaneous Injection of Testosterone Is an Effective and Preferred Alternative to Intramuscular Injection: Demonstration in Female-to-Male Transgender Patients. The Journal of Clinical Endocrinology & Metabolism, 102, 2349–2355.
Wilson, D., Kiang, T., & Ensom, M. (2018). Pharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender‐affirming therapy: A pilot study. American Journal of Health-System Pharmacy, 75, 351–358.
